SEC Comment Letter for PURPLE BIOTECH LTD. (PPBT) (CIK 0001614744) (PPBT) — Jan 6, 2020
PURPLE BIOTECH LTD. (PPBT) (CIK 0001614744)
Date: Jan. 6, 2020 · CIK: 0001614744 · Accession: 0000000000-20-000115
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-235729
Letter
January 6, 2020 Isaac Israel Chief Executive Officer Kitov Pharma Ltd. One Azrieli Center, Round Tower 132 Menachem Begin Road Tel Aviv 6701101, Israel Re:Kitov Pharma Ltd. Registration Statement on Form F-1 Filed December 27, 2019 File No. 333-235729 Dear Mr. Israel: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Rick Werner, Esq.
Show Raw Text
January 6, 2020
Isaac Israel
Chief Executive Officer
Kitov Pharma Ltd.
One Azrieli Center, Round Tower
132 Menachem Begin Road
Tel Aviv 6701101, Israel
Re:Kitov Pharma Ltd.
Registration Statement on Form F-1
Filed December 27, 2019
File No. 333-235729
Dear Mr. Israel:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Rick Werner, Esq.